Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$57.02 USD

57.02
591,898

+0.73 (1.30%)

Updated Jul 17, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

BD's (BDX) Latest PFS Launch to Boost Production Efficiencies

BD's (BDX) newest product offering is expected to set a new standard in performance for vaccine PFS with new and strict specifications for improved production efficiencies.

Haemonetics (HAE) to Offer Two VASCADE Devices in the EU

Haemonetics' (HAE) VASCADE and VASCADE MVP devices help patients attain hemostasis more quickly and with lesser complications.

Cardinal Health (CAH) Lowers Medical Segment Income Guidance

Cardinal Health (CAH) projects Medical segment loss to be in the range of $25 million to $55 million for the first quarter of fiscal 2023, owing to inventory charges related to the company's gloves portfolio.

Looking for a Growth Stock? 3 Reasons Why AMN Healthcare (AMN) is a Solid Choice

AMN Healthcare (AMN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Urmimala Biswas headshot

3 Medical Services Stocks Braving Near-Term Industry Headwinds

The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, AMN and MODV are set to gain the most. However, staffing shortages may disrupt the trend.

3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Merit Medical's (MMSI) Latest Launch to Boost Patient Care

Merit Medical's (MMSI) latest addition to its portfolio is expected to ease access to difficult anatomy in the peripheral vasculature, thereby serving a wider patient pool.

AmerisourceBergen (ABC) to Buy Germany's PharmaLex for $1.3B

AmerisourceBergen (ABC) inks a deal to acquire PharmaLex to support its goal to become a strategic partner of choice for pharma customers for clinical and commercial enablement solutions.

Alcon (ALC) Faces Cost Pressure, Supply Chain Disruption

Given the supply chain challenges, unfavorable foreign exchange impact and inflationary pressure, Alcon (ALC) reduces its core EPS and net sales expectations for 2022.

Here's Why Investors Should Retain Syneos Health (SYNH) for Now

Investors are optimistic about Syneos Health's (SYNH) better-than-expected earnings and robust segmental results.

Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve

Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.

Why Should You Add Ensign Group (ENSG) to Portfolio Now?

Ensign Group (ENSG) benefits from a growing healthcare portfolio as a result of multiple facility buyouts. Solid cash-generating abilities empower ENSG to invest in growth-related initiatives.

Here's Why You Should Hold on to Ecolab (ECL) Stock Now

Investors continue to be optimistic about Ecolab (ECL) owing to its strong business.

Globus Medical (GMED) Gains Market Share, Cost Woes Stay

Globus Medical (GMED) U.S. sales increase, driven by competitive rep conversions and robotic pull-through.

Here's Why You Should Retain West Pharmaceutical (WST) Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

AMN or DOCS: Which Is the Better Value Stock Right Now?

AMN vs. DOCS: Which Stock Is the Better Value Option?

Charles River (CRL) to Support Cure AP-4's Clinical Trials

Charles River's (CRL) manufacturing collaboration with Cure AP-4 will support the latter's Phase I/II gene therapy trials for a rare neurodegenerative disorder.

AMN Healthcare Services (AMN) Gains But Lags Market: What You Should Know

AMN Healthcare Services (AMN) closed the most recent trading day at $106.10, moving +0.31% from the previous trading session.

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.

Zimmer Biomet (ZBH) Procedure Recovery Strong, Margin Woe Stays

Zimmer Biomet's (ZBH) recently completed spin-off of the non-core dental and spine business is expected to prove strategic.

Here's Why Investors Should Retain Abbott (ABT) Stock Now

Strong results across the EPD, diagnostics and medical devices businesses are driving Abbott's (ABT) top line.

UnitedHealth Group (UNH) Ties Up to Aid Medicare Members

UnitedHealth Group (UNH) teams up with Walmart to follow a collaborative approach in extending advanced healthcare services to Medicare members at specific Walmart Health locations.

Abbott (ABT) Debuts Amplatzer Talisman System in Europe

Abbott's (ABT) Amplatzer Talisman PFO Occlusion System will enable doctors across Europe to treat people experiencing a patent foramen ovale-associated stroke.

Accuray's (ARAY) Latest Collaboration to Improve Patient Care

Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.

Glaukos (GKOS) Up on Positive Glaucoma Study Data on iDose TR

Glaukos' (GKOS) targeted injectable implant candidate, iDose TR, achieves a non-inferior reduction in IOP in patients with open-angle glaucoma versus daily treatment with timolol.